Use of Tokyo Guidelines (TG-18) for Acute Cholangitis Provides Improved Specificity and Accuracy Compared to Fellow Clinical Assessment: A US Academic Center Pilot Study

2021 ◽  
Vol 161 (1) ◽  
pp. e22
Author(s):  
Ahmad Alkaddour ◽  
Amit Hudgi ◽  
Anabel Liyen Cartelle ◽  
Amr Ahmed ◽  
Carlos Palacio ◽  
...  
2021 ◽  
Vol 160 (6) ◽  
pp. S-391-S-392
Author(s):  
Ahmad Alkaddour ◽  
Amit Hudgi ◽  
Anabel Liyen Cartelle ◽  
Amr Ahmed ◽  
Carlos Palacio ◽  
...  

2021 ◽  
pp. 1-9
Author(s):  
Ramkumar Mohan ◽  
Stefanie Wei Lynn Goh ◽  
Guan Wei Tan ◽  
Yen Pin Tan ◽  
Sameer P. Junnarkar ◽  
...  

<b><i>Background:</i></b> Acute cholangitis (AC) is a common emergency with a significant mortality risk. The Tokyo Guidelines (TG) provide recommendations for diagnosis, severity stratification, and management of AC. However, validation of the TG remains poor. This study aims to validate TG07, TG13, and TG18 criteria and identify predictors of in-hospital mortality in patients with AC. <b><i>Methods:</i></b> This is a retrospective audit of patients with a discharge diagnosis of AC in the year 2016. Demographic, clinical, investigation, management and mortality data were documented. We performed a multinomial logistic regression analysis with stepwise variable selection to identify severity predictors for in-hospital mortality. <b><i>Results:</i></b> Two hundred sixty-two patients with a median age of 75.9 years (IQR 64.8–82.8) years were included for analysis. TG13/TG18 diagnostic criteria were more sensitive than TG07 diagnostic criteria (85.1 vs. 75.2%; <i>p</i> &#x3c; 0.006). The majority of the patients (<i>n</i> = 178; 67.9%) presented with abdominal pain, pyrexia (<i>n</i> = 156; 59.5%), and vomiting (<i>n</i> = 123; 46.9%). Blood cultures were positive in 95 (36.3%) patients, and 79 (83.2%) patients had monomicrobial growth. The 30-day, 90-day, and in-hospital mortality numbers were 3 (1.1%), 11 (4.2%), and 15 (5.7%), respectively. In multivariate analysis, type 2 diabetes mellitus (OR = 12.531; 95% CI 0.354–116.015; <i>p</i> = 0.026), systolic blood pressure &#x3c;100 mm Hg (OR = 10.108; 95% CI 1.094–93.395; <i>p</i> = 0.041), Glasgow coma score &#x3c;15 (OR = 38.16; 95% CI 1.804–807.191; <i>p</i> = 0.019), and malignancy (OR = 14.135; 95% CI 1.017–196.394; <i>p</i> = 0.049) predicted in-hospital mortality. <b><i>Conclusion:</i></b> TG13/18 diagnostic criteria are more sensitive than TG07 diagnostic criteria. Type 2 diabetes mellitus, systolic blood pressure &#x3c;100 mm Hg, Glasgow coma score &#x3c;15, and malignant etiology predict in-hospital mortality in patients with AC. These predictors could be considered in acute stratification and treatment of patients with AC.


HPB ◽  
2019 ◽  
Vol 21 ◽  
pp. S815
Author(s):  
E. Pando Rau ◽  
P. Alberti Delgado ◽  
L. Blanco Cuso ◽  
M. Caralt Barba ◽  
C. Dopazo Taboada ◽  
...  

2013 ◽  
Vol 21 (2) ◽  
pp. 113-119 ◽  
Author(s):  
Gang Sun ◽  
Lu Han ◽  
Yunsheng Yang ◽  
Enqiang Linghu ◽  
Wen Li ◽  
...  

2013 ◽  
Vol 35 (4) ◽  
pp. 249-257 ◽  
Author(s):  
Toshihiko MAYUMI ◽  
Kazuki SOMEYA ◽  
Hiroki OOTUBO ◽  
Tatsuo TAKAMA ◽  
Takashi KIDO ◽  
...  

2015 ◽  
Vol 81 (5) ◽  
pp. AB365
Author(s):  
Takayoshi Nishino ◽  
Tetsuya Hamano ◽  
Izumi Shirato ◽  
Yutaka Mitsunaga ◽  
Miho Shirato ◽  
...  

2007 ◽  
Vol 14 (1) ◽  
pp. 52-58 ◽  
Author(s):  
Keita Wada ◽  
Tadahiro Takada ◽  
Yoshifumi Kawarada ◽  
Yuji Nimura ◽  
Fumihiko Miura ◽  
...  

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S101-S101
Author(s):  
Ahmed Hamdi ◽  
Zachary A Yetmar ◽  
Alexander T Miller ◽  
Mark Diaz ◽  
Madiha Fida ◽  
...  

Abstract Background Optimum duration of antimicrobial therapy for acute bacteremic cholangitis is not well established; however, 4–7 days is recommended by the 2018 Tokyo guidelines in those without Gram-positive bacteremia. Methods A retrospective study performed at Mayo Clinic - Rochester, Florida and Arizona sites was conducted, reviewing all adult patients with the first episode of acute cholangitis secondary to biliary stone obstruction, between January 1, 2012 and December 31, 2017. We reviewed the duration of prescribed antimicrobials. Results Among 331 included cases, 197(60%) were men, 66 (20%) were immuno-compromised. Presenting symptoms included fever in 202 (61.5%), abdominal pain in 289 (87%), jaundice 128(38.7%), and altered mentation in 49 (15%). Among these, 256 (77%) were classified as “definite” and 38 (11.5%) were “suspected” using the 2018 Tokyo guideline classification. Cholangitis grade was grade III in 134 (40.5%); grade II in 115 (34.7%); and grade I in 82 (24.8%). Majority of cases, 321 (97%), underwent source control—most commonly 309 (96%) achieved by endoscopic retrograde cholangiopancreatography (ERCP). Source control occurred within 24 hr of presentation in 197 (61.4%) of the cases. Bacteremia was documented in 131/277 (47%). Majority of bacteremias were due to Gram-negative organisms in 119 (91%). Mean duration of antibiotic therapy following “source control” was 9.6 days (SD 7.0). Cases with bacteremia, resulted in longer treatment duration, mean of 13 days (SD 5.6), regardless of the isolated organism. Overall 30 day mortality was 14/331 (4.2%). No mortality difference was noted in patients who underwent early (within 12 hours) vs. later source control (4.55% Vs. 4.53%), nor in those who received more or less than 6 days of antibiotic therapy after source control (4.7% Vs. 3.9%, P = 0.76). No difference in mortality was observed in those with or without bacteremia. Conclusion Our results note the use of longer courses of antimicrobials for management of bacteremic cholangitis, regardless of the organism type. This population could be a prime target for an antimicrobial stewardship intervention, to decrease the duration of prescribed antimicrobials in accordance with recent guidelines. Disclosures All authors: No reported disclosures.


Sign in / Sign up

Export Citation Format

Share Document